Skip Navigation

Coronavirus: How Globalization and Our Regulatory Structure Caught the U.S. Off Hand (Guest: Dr. Jane Orient, M.D.)

March 20, 2020

COVID-19 is a mysterious threat with no end in sight. It is shutting down economies. It the response warranted? Was it necessary?

In this podcast, AnneMarie Schieber and Dr. Jane Orient, M.D. discuss:

- How South Korea’s rapid response has kept COVID-19 at bay.  How could South Korea so rapidly developed tests

- Why it may be important to test for antibodies to coronavirus

- The computer modeling the Administration is relying on for mitigation measures

- Random sampling testing and whether false results could provide more harm than good

- How China, France are experimenting with treatment, in particular anti-malaria and HIV drugs, and Vitamin C…what is holding the U.S. back?

Dr. Jane Orient, M.D. also discusses how bureaucracy at our government agencies, the Food and Drug Administration and the Centers for Disease Control and Prevention, stalled the early rollout of testing and how globalization of the supply chain will hamper efforts to treat the disease.

Article Tags
Health Care
Author
Jane M. Orient, M.D. is executive director of the Association of American Physicians and Surgeons and president of Doctors for Disaster Preparedness.
janeorientmd@gmail.com @jorient
Author
AnneMarie Schieber is a research fellow at The Heartland Institute and managing editor of Health Care News, Heartland's monthly newspaper for health care reform.
amschieber@heartland.org @HCPolicy